MDedge Cardiology

Apr 15, 2024 | mdedge.com | MDedge Cardiology |Ted Bosworth |Unclear Mechanisms

Publish date: April 15, 2024 — Unlike traditional antidiabetic therapies, which have never been associated with a significant reduction in stroke in a major trial, some of the newer drugs are showing that benefit, but the protection is not linked to tighter glycemic control. In patients with type 2 diabetes mellitus (T2DM), the evidence is strong that “they are not working through glycemic control per se,” according to Larry B.